Drug intelligence / Profile preview

SC DERM Recon

Development stage: Unknown
Lead developer: DOF
Administration: Implantation

Overview

SC DERM Recon is an acellular dermal matrix (ADM) biological scaffold developed by DOF Inc. for use in breast reconstruction surgery. It is derived from human skin tissue and processed using a proprietary supercritical carbon dioxide (CO2) technology. This method is designed to effectively remove cellular components and immunogenic materials while maintaining the structural and biochemical integrity of the extracellular matrix (ECM) better than traditional detergent-based methods. In clinical applications, such as implant-based breast reconstruction following mastectomy, the matrix is used to wrap or support the implant, facilitating tissue integration and improving aesthetic results.

Brand names: SC DERM ReconSC DERM
Other names: acellular dermal matrix-DOF Inc.supercritical carbon dioxide processed acellular dermal matrix

Beyond the preview

Go deeper on SC DERM Recon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SC DERM Recon.

Explore the full profile